Barry Flannelly
Fortune : 4 M $ au 31/10/2026
Fortune : 4 M $ au 31/10/2026
Barry P Flannelly is an Independent Director at Protara Therapeutics, Inc. since 2020.
Former roles include Executive VP & General Manager-North America at Incyte Corp.
from 2015 to 2025, Chief Executive Officer at OSS Healthcare, Inc. from 2013 to 2014, Director at Genomic Health, Inc. in 2019, VP-Global Product Strategy & Commercial Planning at Nektar Therapeutics from 2011 to 2013, Senior Vice President-Commercial at Onyx Pharmaceuticals, Inc. from 2008 to 2011, and Manager-Pharmacy Services at Johns Hopkins Oncology Center.
Education includes undergraduate studies at Massachusetts College of Pharmacy & Health Science, an MBA from the University of Baltimore, and a doctorate from the University of Maryland School of Pharmacy.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INCYTE CORPORATION 0,02% | 16/07/2025 | 35 149 ( 0,02% ) | 4 M $ | 31/10/2026 |
| 15/06/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/07/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 31/07/2025 |
| GENOMIC HEALTH, INC. | Directeur/Membre du Conseil | 08/11/2019 |
OSS Healthcare, Inc. | Directeur Général | 01/07/2014 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/04/2013 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 01/01/2011 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Genomic Health, Inc.
Genomic Health, Inc. Medical/Nursing ServicesHealth Services Engages in genomic-based diagnostic tests for overtreatment and optimal treatment of early stage cancer | Health Services |
Massachusetts College of Pharmacy & Health Science
Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Baltimore
University of Baltimore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OSS Healthcare, Inc. | |
University of Maryland School of Pharmacy
University of Maryland School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protara Therapeutics, Inc.
Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Johns Hopkins Oncology Center |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national